Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „zonisamide“
Suchtreffer
Begriffe & Kennungen
Zonegran · 4.5 · - Enzyme induction: Exposure to zonisamide is lower in epileptic patients receiving CYP3A4-inducing agents suc
Eintrag öffnenZonegran · 4.5 · - Enzyme induction: Exposure to zonisamide is lower in epileptic patients receiving CYP3A4-inducing agents suc
Eintrag öffnenZonegran · 4.5 · - Enzyme induction: Exposure to zonisamide is lower in epileptic patients receiving CYP3A4-inducing agents suc
Eintrag öffnenZonegran · 4.5 · In clinical studies co-administration of lamotrigine had no apparent effect on zonisamide pharmacokinetics. Th
Eintrag öffnenZonegran · 4.5 · In clinical studies co-administration of lamotrigine had no apparent effect on zonisamide pharmacokinetics. Th
Eintrag öffnenZonegran · 4.5 · In clinical studies co-administration of lamotrigine had no apparent effect on zonisamide pharmacokinetics. Th
Eintrag öffnenZonegran · 4.5 · P-gp substrate An in vitro study shows that zonisamide is a weak inhibitor of P-gp (MDR1) with an IC 50 of 267
Eintrag öffnenZonegran · 4.5 · P-gp substrate An in vitro study shows that zonisamide is a weak inhibitor of P-gp (MDR1) with an IC 50 of 267
Eintrag öffnenZonegran · 4.5 · P-gp substrate An in vitro study shows that zonisamide is a weak inhibitor of P-gp (MDR1) with an IC 50 of 267
Eintrag öffnenZonegran · 4.5 · Zonisamide is metabolised partly by CYP3A4 (reductive cleavage), and also by N-acetyl-transferases and conjuga
Eintrag öffnenZonegran · 4.5 · Zonisamide is metabolised partly by CYP3A4 (reductive cleavage), and also by N-acetyl-transferases and conjuga
Eintrag öffnenZonegran · 4.5 · Zonisamide is metabolised partly by CYP3A4 (reductive cleavage), and also by N-acetyl-transferases and conjuga
Eintrag öffnenZonegran · 4.8 · 35 Paediatric population The adverse event profile of zonisamide in paediatric patients aged 6 to 17 years in
Eintrag öffnenZonegran · 4.8 · Paediatric population The adverse event profile of zonisamide in paediatric patients aged 6 to 17 years in pla
Eintrag öffnenZonegran · 4.8 · Paediatric population The adverse event profile of zonisamide in paediatric patients aged 6 to 17 years in pla
Eintrag öffnenZonegran · 4.8 · Table 5. Adverse reactions in a randomised, controlled monotherapy trial comparing zonisamide with carbamazepi
Eintrag öffnenZonegran · 4.8 · Table 5. Adverse reactions in a randomised, controlled monotherapy trial comparing zonisamide with carbamazepi
Eintrag öffnenZonegran · 4.8 · Table 5. Adverse reactions in a randomised, controlled monotherapy trial comparing zonisamide with carbamazepi
Eintrag öffnenZonisamid
Eintrag öffnenzonisamide
Eintrag öffnen